Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunkeding granules vs betahistine for vertebrobasilar insufficiency vertigo
CTR20132159Phase 2Completed
- Sponsor
- Hefei Jingfang Pharmaceutical Technology Development
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of betahistine in Vertebrobasilar Atherosclerosis, vertigo, sponsored by Hefei Jingfang Pharmaceutical Technology Development. Started Mar 2014; status: completed.
02
Drugs
betahistine
03
Conditions
Vertebrobasilar Atherosclerosisvertigo
Beyond the preview
Go deeper on CTR20132159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132159.